# Johannes Levin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/johannes-levin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,986 |
| Field | Alzheimer's disease research and treatments |
| h-index | 74 |
| i10-index | 320 |
| Last Known Institution | German Center for Neurodegenerative Diseases |
| OpenAlex ID | https://openalex.org/A5035514608 |
| ORCID iD | https://orcid.org/0000-0001-5092-4306 |
| Works | 729 |

## Researcher papers

- [Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria](https://scholariq.org/papers/clinical-diagnosis-of-progressive-supranuclear-palsy-the-movement-disorder/)
- [Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study](https://scholariq.org/papers/spatial-patterns-of-neuroimaging-biomarker-change-in-individuals-from-families/)
- [Hough-CNN: Deep learning for segmentation of deep brain regions in MRI and ultrasound](https://scholariq.org/papers/hough-cnn-deep-learning-for-segmentation-of-deep-brain-regions-in-mri-and/)
- [Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study](https://scholariq.org/papers/age-at-symptom-onset-and-death-and-disease-duration-in-genetic-frontotemporal/)
- [Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases](https://scholariq.org/papers/microglial-activation-states-drive-glucose-uptake-and-fdg-pet-alterations-in/)
- [Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS](https://scholariq.org/papers/plasma-extracellular-vesicle-tau-and-tdp-43-as-diagnostic-biomarkers-in-ftd-and/)
- [Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease](https://scholariq.org/papers/cerebrospinal-fluid-proteomics-define-the-natural-history-of-autosomal-dominant/)
- [Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial](https://scholariq.org/papers/behavioural-outcomes-of-subthalamic-stimulation-and-medical-therapy-versus/)
- [Which ante mortem clinical features predict progressive supranuclear palsy pathology?](https://scholariq.org/papers/which-ante-mortem-clinical-features-predict-progressive-supranuclear-palsy/)
- [Temporal order of clinical and biomarker changes in familial frontotemporal dementia](https://scholariq.org/papers/temporal-order-of-clinical-and-biomarker-changes-in-familial-frontotemporal/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)

## Researcher university

- [German Center for Neurodegenerative Diseases](https://scholariq.org/institutions/german-center-for-neurodegenerative-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.